Objective: This study aimed to assess whether the evaluation of the central vein sign (CVS) and paramagnetic rim lesions (PRLs) using susceptibility-weighted magnetic resonance imaging (MRI) can distinguish multiple sclerosis (MS) from migraine. Materials and Methods: In this single-center observational study, we conducted a cross-sectional analysis of the CVS, determining the proportion of CVS-positive lesions per individual and absolute counts, using thresholds of 3 lesions (select3*) and 6 lesions (select6*), and of PRLs in participants with MS and in those with migraine, from 3.0-T MRI brain scans. Results: The study included 20 participants with MS, 20 with migraine, and 20 included as healthy controls. The proportion of participants with CVS-positive lesions was higher in the MS group than in the migraine group (61.8% vs. 10.4%), and PRLs were observed exclusively in the MS group. The presence of at least one PRL and the select6* criterion demonstrated the highest diagnostic accuracy within the study sample. Conclusion: The detection of the CVS and of a PRL on 3.0-T MRI scans may serve as a reliable biomarker to differentiate MS from migraine.
1 January 2024 in Clinical and Biomedical Research
Introduction: Multiple sclerosis may rarely present alongside idiopathic thrombocytopenic purpura and scarcely ever following splenectomy for hematologic disease. Methods and Results: We report the case of a 51-year-old woman presenting with subacute onset of mild ataxia, dysarthria and lower limb dysesthesia in close temporal relationship with splenectomy performed as a treatment for steroid-dependent idiopathic thrombocytopenic purpura. MRI showed hyperintense T2/FLAIR multifocal white-matter lesions and there were highly positive cerebrospinal-fluid oligoclonal bands, picturing her first clinical episode of multiple sclerosis. She was treated with intravenous methylprednisolone, with significant improvement, and then started on multiple sclerosis disease-modifying therapy. Conclusion: This report suggests the possible role of splenectomy as an environmental trigger for clinical multiple sclerosis in genetically predisposed individuals, as well as for those with radiologically isolated syndrome. Introdução: A esclerose múltipla pode raramente apresentar-se em concomitância com a púrpura trombocitopênica idiopática e, excepcionalmente, após esplenectomia por doença hematológica. Métodos e Resultados: Relatamos o caso de uma mulher de 51 anos que apresentou início subagudo de ataxia leve, disartria e disestesia de membros inferiores em estreita relação temporal com esplenectomia realizada como tratamento para púrpura trombocitopênica idiopática cortico-dependente. A ressonância magnética mostrou lesões multifocais hiperintensas na substância branca em T2/FLAIR e foi evidenciada a presença de bandas oligoclonais exclusivas no líquor, caracterizando seu primeiro surto clínico de esclerose múltipla. Foi tratada com metilprednisolona intravenosa, com melhora significativa, e posteriormente submetida a terapia modificadora da doença para esclerose múltipla. Conclusão: Este relato de caso sugere o possível papel da esplenectomia como gatilho para o desencadeamento de esclerose múltipla clinicamente manifesta em indivíduos geneticamente predispostos, bem como para aqueles com síndrome radiologicamente isolada.